FTM

First Turn Management Portfolio holdings

AUM $895M
1-Year Est. Return 261.28%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+261.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$895M
AUM Growth
+$19.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$23M
2
+$20.5M
3
+$17.3M
4
PVLA
Palvella Therapeutics
PVLA
+$15.4M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$12.8M

Top Sells

1
+$27.7M
2
+$22.4M
3
+$19.6M
4
RVMD icon
Revolution Medicines
RVMD
+$17.2M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$15.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TERN
26
DELISTED
Terns Pharmaceuticals
TERN
$17.2M 1.92%
326,694
-545,355
VERA icon
27
Vera Therapeutics
VERA
$2.35B
$17M 1.9%
422,023
-179,751
NTRA icon
28
Natera
NTRA
$31.7B
$16.2M 1.81%
81,077
+202
ERAS icon
29
Erasca
ERAS
$4.19B
$14M 1.57%
+867,639
PRAX icon
30
Praxis Precision Medicines
PRAX
$7.54B
$13.7M 1.53%
42,441
+6,692
OLMA icon
31
Olema Pharmaceuticals
OLMA
$915M
$11.5M 1.28%
768,662
+150,948
QURE icon
32
uniQure
QURE
$1.92B
$10.1M 1.12%
615,489
+293,834
MLTX icon
33
MoonLake Immunotherapeutics
MLTX
$1.35B
$5.88M 0.66%
315,563
+52,920
ARGX icon
34
argenx
ARGX
$52.5B
– –
-23,256
GH icon
35
Guardant Health
GH
$17.3B
– –
-271,685
IRON icon
36
Disc Medicine
IRON
$2.72B
– –
-153,206
RCUS icon
37
Arcus Biosciences
RCUS
$3.16B
– –
-565,142
RYTM icon
38
Rhythm Pharmaceuticals
RYTM
$5.94B
– –
-146,303
1
2